The National Cancer Institute is offering the Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers grant. This grant is for the primary purpose of establishing an agile and effective network infrastructure. This infrastructure will foster collaborative research dedicated to discovering novel molecularly or immunologically targeted agents. These agents are specifically designed to prevent or intercept the oncogenic process in high-risk populations. The ultimate goal is to enable precision cancer prevention and interception. Through this initiative, the department aims to accelerate the identification and development of innovative strategies, significantly improving the ability to stop cancer before it fully manifests.
Opportunity ID: 334778
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-21-038 |
| Funding Opportunity Title: | Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 16, 2021 |
| Last Updated Date: | Jul 16, 2021 |
| Original Closing Date for Applications: | Oct 07, 2021 |
| Current Closing Date for Applications: | Oct 07, 2021 |
| Archive Date: | Nov 12, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Special district governments For profit organizations other than small businesses Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments Independent school districts County governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The overall goal of this FOA and the companion FOA is to establish an agile and effective network infrastructure that undertakes collaborative research to discover molecularly or immunologically targeted agents designed to prevent or intercept oncogenic process in high-risk populations for precision cancer prevention and interception. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-21-038.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268235 | Sep 07, 2021 | Jan 24, 2022 | View |
Package 1
Mandatory forms
334778 RR_SF424_2_0-2.0.pdf
334778 PHS398_CoverPageSupplement_5_0-5.0.pdf
334778 RR_OtherProjectInfo_1_4-1.4.pdf
334778 PerformanceSite_2_0-2.0.pdf
334778 RR_KeyPersonExpanded_2_0-2.0.pdf
334778 PHS398_ResearchPlan_4_0-4.0.pdf
334778 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
334778 PHS_Additional_IndirectCosts-1.0.pdf
334778 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
